Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ceribell Inc (CBLL)

Ceribell Inc (CBLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 757,129
  • Shares Outstanding, K 37,096
  • Annual Sales, $ 65,440 K
  • Annual Income, $ -40,460 K
  • EBIT $ -57 M
  • EBITDA $ -55 M
  • 60-Month Beta 1.35
  • Price/Sales 11.44
  • Price/Cash Flow N/A
  • Price/Book 4.51

Options Overview Details

View History
  • Implied Volatility 107.22% (-1.75%)
  • Historical Volatility 59.03%
  • IV Percentile 51%
  • IV Rank 30.47%
  • IV High 208.93% on 10/15/25
  • IV Low 62.64% on 03/03/25
  • Expected Move (DTE 7) 0.89 (4.25%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 326
  • Open Int (30-Day) 280
  • Expected Range 20.09 to 21.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.42
  • Number of Estimates 5
  • High Estimate -0.39
  • Low Estimate -0.48
  • Prior Year -0.40
  • Growth Rate Est. (year over year) -5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.36 +70.27%
on 11/13/25
24.25 -13.22%
on 12/09/25
+8.19 (+63.77%)
since 11/12/25
3-Month
10.85 +93.96%
on 11/04/25
24.25 -13.22%
on 12/09/25
+9.48 (+81.89%)
since 09/12/25
52-Week
10.01 +110.24%
on 04/10/25
29.96 -29.76%
on 12/13/24
-8.16 (-27.93%)
since 12/12/24

Most Recent Stories

More News
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SUNNYVALE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)
Ceribell Reports Third Quarter 2025 Financial Results

SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)
William Blair Keeps Their Buy Rating on Ceribell, Inc. (CBLL)

William Blair analyst Brandon Vazquez maintained a Buy rating on Ceribell, Inc. today. The company’s shares opened today at $11.90.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

CBLL : 20.89 (+2.35%)
Medtech Leader Erica Rogers Joins Ceribell Board of Directors

SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management...

CBLL : 20.89 (+2.35%)
Ceribell Reports Second Quarter 2025 Financial Results

SUNNYVALE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 20.89 (+2.35%)

Business Summary

CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs...

See More

Key Turning Points

3rd Resistance Point 21.02
2nd Resistance Point 20.74
1st Resistance Point 20.57
Last Price 20.89
1st Support Level 20.12
2nd Support Level 19.84
3rd Support Level 19.67

See More

52-Week High 29.96
Fibonacci 61.8% 22.34
Last Price 20.89
Fibonacci 50% 19.99
Fibonacci 38.2% 17.63
52-Week Low 10.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar